Methamphetamine (METH) addiction currently presents an enormous public health issue, and yet no therapeutic agent is currently approved for its treatment. Psychostimulant addiction is a chronic, progressive disease driven by numerous persistent neurophysiological adaptations. METH self-administration increases input of the neuropeptide neurotensin onto dopamine (DA) neurons in the ventral tegmental area (VTA), which are extensively implicated in drug reward processes. While literature evidence and our preliminary results suggest that neurotensin decreases DA autoreceptor-mediated signaling, the role of DA D2 autoreceptors in drug self-administration has not been described. We have recently identified what had been a missing tool in the study of DA autoreceptors and DA-mediated synaptic transmission: an inhibitory postsynaptic current (or IPSC) mediated directly by dendrodendritic DA neurotransmission in the VTA. The identification of the DA IPSC allows us, for the first time, to directly address synaptic questions concerning the relationship between METH abuse and DA neurotransmission. The goal of this application is to determine key synaptic adaptations at the level of the DA cell body that are responsible for escalating METH self-administration. Our central hypothesis is that METH use decreases D2 autoreceptor signaling in VTA DA neurons through a neurotensin-dependent rise in intracellular calcium, producing an escalation of METH self-administration behavior. We will test this by combining patch clamp electrophysiology in brain slices with intravenous METH self-administration and VTA site-specific drug microinjections in mice. The studies in Aim 1 will determine the mechanisms responsible for long-term depression of the DA IPSC. The hypothesis to be tested is that that long term depression of DA IPSCs is produced by a neurotensin receptor-dependent rise in intracellular calcium producing the activation of protein phosphatase 3. The studies in Aim 2 will determine the changes in the DA IPSC produced by METH self-administration. The hypothesis to be tested is that in vivo contingent METH self-administration decreases autoreceptor signaling through a neurotensin-dependent mechanism. The studies in Aim 3 will determine the role of DA autoreceptor-mediated neurotransmission on the escalation of METH self-administration. The hypothesis to be tested is that autoreceptor signaling directly limits METH intake, and that neurotensin-induced depression of this signal contributes to the escalation of self-administration observed with prolonged access to the drug. The results of these studies will identify key cellular mechanisms responsible for decreased autoreceptor signaling, and will determine how this decrease in dendrodendritic DA neurotransmission produces escalation of METH self-administration. These findings will provide a detailed understanding of the relationship between neurotensin, DA neuron activity and METH self-administration and will lay the foundation for therapeutics targeting neurotensin- and autoreceptor-mediated signaling.
METH abuse represents a serious public health issue, but the neurophysiological mechanisms responsible for its effects are not adequately understood. By combining electrophysiological, pharmacological and behavioral techniques we can elucidate the synaptic alterations responsible for the increasing drug self-administration that is characteristic of the early stages of addiction. The mechanistic understanding gleaned from these studies could thus identify therapeutic targets to treat or prevent drug addiction.
|Donegan, J J; Tyson, J A; Branch, S Y et al. (2017) Stem cell-derived interneuron transplants functionally integrate within the existing circuitry. Mol Psychiatry 22:1369|
|Donegan, J J; Tyson, J A; Branch, S Y et al. (2017) Stem cell-derived interneuron transplants as a treatment for schizophrenia: preclinical validation in a rodent model. Mol Psychiatry 22:1492-1501|
|Avelar, Alicia J; Cao, Jianjing; Newman, Amy Hauck et al. (2017) Atypical dopamine transporter inhibitors R-modafinil and JHW 007 differentially affect D2 autoreceptor neurotransmission and the firing rate of midbrain dopamine neurons. Neuropharmacology 123:410-419|
|Sharpe, Amanda L; Varela, Erika; Beckstead, Michael J (2017) Systemic PD149163, a neurotensin receptor 1 agonist, decreases methamphetamine self-administration in DBA/2J mice without causing excessive sedation. PLoS One 12:e0180710|
|McCall, Nora M; Kotecki, Lydia; Dominguez-Lopez, Sergio et al. (2017) Selective Ablation of GIRK Channels in Dopamine Neurons Alters Behavioral Effects of Cocaine in Mice. Neuropsychopharmacology 42:707-715|
|Dominguez-Lopez, Sergio; Piccart, Elisabeth; Lynch, William B et al. (2017) Antagonism of neurotensin receptors in the ventral tegmental area decreases methamphetamine self-administration and methamphetamine seeking in mice. Int J Neuropsychopharmacol :|
|Branch, Sarah Y; Chen, Cang; Sharma, Ramaswamy et al. (2016) Dopaminergic Neurons Exhibit an Age-Dependent Decline in Electrophysiological Parameters in the MitoPark Mouse Model of Parkinson's Disease. J Neurosci 36:4026-37|
|Piccart, Elisabeth; Courtney, Nicholas A; Branch, Sarah Y et al. (2015) Neurotensin Induces Presynaptic Depression of D2 Dopamine Autoreceptor-Mediated Neurotransmission in Midbrain Dopaminergic Neurons. J Neurosci 35:11144-52|
|Paredes, R Madelaine; Piccart, E; Navaira, E et al. (2015) Physiological and behavioral effects of amphetamine in BACE1(-/-) mice. Genes Brain Behav 14:411-8|
|Sharpe, Amanda L; Varela, Erika; Bettinger, Lynne et al. (2014) Methamphetamine self-administration in mice decreases GIRK channel-mediated currents in midbrain dopamine neurons. Int J Neuropsychopharmacol 18:|
Showing the most recent 10 out of 12 publications